Hi-Tech Pharmacal Recalls Subpotent HydrOXYzine Hydrochloride Oral Solution
Hi-Tech Pharmacal is recalling specific lots of HydrOXYzine Hydrochloride Oral Solution because the product failed stability testing and may be subpotent.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences. The hazard is a subpotent medication, which is a quality issue rather than a direct safety hazard like contamination or injury.
Plain-English summary
Hi-Tech Pharmacal Co., Inc. is recalling HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL), Rx Only. The recall involves two specific lots: Batch 608917 (expiration date 02/2014) and Batch 608204 (expiration date 01/2014). The total quantity recalled is 15,240 bottles.
The reason for the recall is that the product failed a 24-month stability test station, resulting in a subpotent classification. This means the medication may not contain the full labeled amount of the active ingredient. The affected products were distributed nationwide and in Puerto Rico.
Consumers and healthcare providers should stop using the recalled product and return it to the pharmacy or point of purchase. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL), Rx Only, HI-TECH PHARMACAL CO., INC. AMITYVILLE, NY, NDC 50383-796-16
- Manufacturer
- Hi-Tech Pharmacal Co., Inc.
- Category
- Drug — Antihistamine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch 608917 (exp. 02/2014)
- and Batch 608204 (exp. 01/2014)
Distribution
Related recalls
Same manufacturer · Hi-Tech Pharmacal Co., Inc.
See all →- LowHi-Tech Pharmacal Recalls Liquid Vitamin C Due to pH Issues
FDA (Food) · 2016-12-28
- LowHi-Tech Pharmacal Recalls Liquid Vitamin C Due to Low Active Ingredient
FDA (Food) · 2016-12-28
- ModerateHi-Tech Pharmacal Recalls Ferrous Sulfate Elixir Due to pH Issues
FDA (Food) · 2015-03-11
- SevereHi-Tech Pharmacal Recalls HydrOXYzine Hydrochloride Oral Solution Due to Impurity
FDA (Drugs) · 2014-11-05
- LowHi-Tech Pharmacal Recalls Acyclovir Oral Suspension for Stability Failures
FDA (Drugs) · 2014-01-01
Same hazard · subpotent
See all →- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- HighCompounded vasopressin syringes recalled as subpotent by IntegraDose Compounding Services
FDA (Drugs) · 2026-06-24
- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
Similar recalls
- SevereHi-Tech Pharmacal Recalls HydrOXYzine Hydrochloride Oral Solution Due to Impurity
FDA (Drugs) · 2014-11-05
- LowHi-Tech Pharmacal Recalls Acyclovir Oral Suspension for Stability Failures
FDA (Drugs) · 2014-01-01
- LowHi-Tech Pharmacal Recalls Subpotent Acetic Acid Otic Solution
FDA (Drugs) · 2013-05-08
- SevereAkorn Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurities
FDA (Drugs) · 2015-06-17
- ModerateAkorn Recalls Hydrocortisone and Acetic Acid Otic Solution Due to Low Potency
FDA (Drugs) · 2019-03-27
- ModerateAkorn Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurity Failures
FDA (Drugs) · 2015-06-17